Novel fatty acids and their use in conjugation to biomolecules

The invention provides a conjugate comprising a biomolecule linked to a fatty acid via a linker wherein the fatty acid has the following Formulae A1, A2 or A3: wherein R1, R2, R3, R4, Ak, n, m and p are defined herein. The invention also relates to a method for manufacturing the conjugate of the inv...

Full description

Saved in:
Bibliographic Details
Main Authors BOSE, AVIRUP, DUTTAROY, ALOKESH, BRUCE, ALEXANDRA MARSHALL, LOU, CHANG-GANG, USERA, AIMEE RICHARDSON, BARNES, DAVID WENINGER, YAMADA, KEN, ZECRI, FREDERIC, IBEBUNJO, CHIKWENDU, KIRMAN, LOUISE CLARE, KANTER, AARON, YUAN, JUN
Format Patent
LanguageChinese
English
Published 01.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides a conjugate comprising a biomolecule linked to a fatty acid via a linker wherein the fatty acid has the following Formulae A1, A2 or A3: wherein R1, R2, R3, R4, Ak, n, m and p are defined herein. The invention also relates to a method for manufacturing the conjugate of the invention such as GDF15 conjugate, and its therapeutic uses such as treatment or prevention of metabolic disorders or diseases, type 2 diabetes mellitus, obesity, pancreatitis, dyslipidemia, alcoholic and nonalcoholic fatty liver disease/steatohepatitis and other progressive liver diseases, insulin resistance, hyperinsulinemia, glucose intolerance, hyperglycemia, metabolic syndrome, hypertension, cardiovascular disease, atherosclerosis, peripheral arterial disease, stroke, heart failure, coronary heart disease, diabetic complications (including but not limited to chronic kidney disease), neuropathy, gastroparesis and other metabolic disorders. The present invention further provides a combination of pharmacologically a
Bibliography:Application Number: TW202110136772